Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease [1]

New England Journal of Medicine

Volumn 358, Issue 7, 2008, Pages 742-743

  Olweny, Charles L M ^a   Ziegler, John L ^b  

^a UGANDA MARTYRS UNIVERSITY   (Uganda)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORMETHINE; PREDNISONE; PROCARBAZINE; VINCRISTINE; ANTINEOPLASTIC AGENT; MUSTARD GAS DERIVATIVE;

CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CHILDHOOD; COMBINATION CHEMOTHERAPY; HODGKIN DISEASE; HUMAN; LETTER; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; TREATMENT RESPONSE; UGANDA; HISTORY; NOTE;

ANTINEOPLASTIC AGENTS; HISTORY, 20TH CENTURY; HODGKIN DISEASE; HUMANS; MUSTARD COMPOUNDS;

EID: 39049157444     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc073375     Document Type: Letter

References (4)

1. Fermé C, Eghbali H, Meerwaldt JH, et al. Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease. N Engl J Med 2007;357:1916-27.
2. Diehl V. Hodgkin's disease - from pathology specimen to cure. N Engl J Med 2007;357:1968-71.
3. Ziegler JL, Fass L, Bluming AZ, Magrath IT, Templeton AC. Chemotherapy of childhood Hodgkin's disease in Uganda. Lancet 1972;2:679-82.
4. Olweny CLM, Katongole-Mbidde E, Kiire C, Lwanga SK, Magrath I, Ziegler JL. Childhood Hodgkin's disease in Uganda: a ten year experience. Cancer 1978;42:787-92.